Differential Transcript Usage

  • Differential transcript usage (DTU) is a bioinformatics approach used to identify changes in the relative abundance of different transcript isoforms produced by the same gene across biological conditions. A single gene can generate multiple transcript isoforms through alternative splicing, alternative transcription start sites, alternative polyadenylation, and other RNA-processing mechanisms. These isoforms may differ in exon composition, coding sequences, untranslated regions, and biological functions. Differential transcript usage analysis determines whether the proportion of individual transcript isoforms changes between tissues, developmental stages, experimental treatments, disease conditions, or other biological groups.
  • Gene expression analysis generally measures the total expression of a gene by combining the abundance of its different transcript isoforms. However, changes in transcript composition may occur without a significant change in total gene expression. For example, a gene may have similar overall expression in two tissues, but one tissue may predominantly express an isoform containing a particular exon, while the other expresses an isoform lacking that exon. Conventional gene-level differential expression analysis may not detect this difference. Differential transcript usage provides a more detailed understanding by examining the relative contribution of each transcript to the total expression of its gene.
  • Differential transcript usage is closely associated with alternative splicing. During RNA processing, introns are removed and exons are joined to produce mature RNA transcripts. Alternative splicing can generate several transcript isoforms from a single gene through exon skipping, alternative 5′ splice-site selection, alternative 3′ splice-site selection, intron retention, and mutually exclusive exon usage. Alternative transcription start sites and alternative polyadenylation can also produce transcripts with different 5′ and 3′ ends. These mechanisms contribute to transcript diversity and can influence protein structure, RNA stability, translation efficiency, and cellular function.
  • The biological consequences of differential transcript usage depend on the structural differences between the affected isoforms. Some transcript switches alter the protein-coding sequence and produce proteins with different amino acid compositions, domains, or functional properties. Other changes affect only the 5′ or 3′ untranslated regions (UTRs), influencing RNA stability, localization, translation, and interactions with microRNAs (miRNAs) or RNA-binding proteins. Some alternative transcripts contain premature termination codons and may be degraded through nonsense-mediated mRNA decay (NMD). Consequently, differential transcript usage can influence biological processes even when total gene expression remains unchanged.
  • RNA sequencing (RNA-seq) is the principal technology used to investigate differential transcript usage. In short-read RNA-seq, RNA molecules are converted into complementary DNA (cDNA), fragmented, and sequenced. The resulting reads are aligned to a reference genome or transcriptome and used to estimate the abundance of individual transcript isoforms. However, short reads may not uniquely distinguish between highly similar transcripts, particularly when isoforms share most of their exons. Computational methods therefore use read distribution, exon coverage, splice junction evidence, transcript structure, and statistical models to estimate transcript abundance and identify changes in transcript usage.
  • A typical differential transcript usage workflow begins with RNA-seq quality assessment using FastQC and MultiQC. Adapter sequences and low-quality bases are removed using Cutadapt or fastp. Clean reads are then processed using alignment-based or lightweight-alignment methods. STAR and HISAT2 can align reads to a reference genome, while Salmon and kallisto can estimate transcript abundance using a transcriptome reference. Transcript annotations from Ensembl, RefSeq, or GENCODE provide the structural information needed to distinguish transcript isoforms. Estimated transcript counts and abundance measurements are subsequently used for statistical analysis.
  • Transcript quantification is an essential step in differential transcript usage analysis. Tools such as Salmon, kallisto, RSEM, and StringTie estimate the abundance of individual transcripts. These estimates may be reported as transcript counts, transcripts per million (TPM), or other normalized measurements. For statistical testing, methods often use estimated counts or appropriately transformed transcript-level data rather than relying only on TPM values. Importing quantification results into R using packages such as tximport can help prepare transcript-level estimates for downstream analysis, including gene-level summarization and differential transcript usage workflows.
  • Differential transcript usage focuses on the relative contribution of individual transcripts to total gene expression. A commonly used measurement is the transcript usage proportion, which represents the fraction of a gene’s expression attributable to a particular isoform.
    • Transcript Usage = Abundance of an Individual Transcript / Total Abundance of All Transcripts from the Gene
  • Here, the numerator represents the estimated abundance of one transcript isoform, while the denominator represents the combined abundance of all quantified isoforms belonging to the same gene. Transcript usage values range from 0 to 1, or can be expressed as percentages. The usage proportions of all isoforms from a gene sum to approximately 1 when calculated from a consistent set of abundance estimates.
  • The change in transcript usage between two biological conditions can be expressed as:
    • ΔTU = TU(condition 1) − TU(condition 2)
  • Here, ΔTU represents the difference in transcript usage, and TU represents the relative proportion of a particular transcript within its gene. A positive value indicates increased usage in condition 1, while a negative value indicates decreased usage in condition 1 relative to condition 2. This difference is often called a change in transcript usage or a change in transcript proportion. Statistical testing is necessary to determine whether the observed difference is significant.
  • Differential transcript usage is different from differential gene expression and differential transcript expression. Differential gene expression examines changes in total gene-level abundance, combining the expression of all transcripts produced by a gene. Differential transcript expression investigates whether the absolute abundance of individual transcripts changes between conditions. Differential transcript usage focuses on changes in the relative proportions of transcripts within a gene. These analyses are related but answer different biological questions and can produce different results.
  • Isoform switching is an important pattern identified through differential transcript usage analysis. It occurs when the predominant transcript of a gene changes between biological conditions. For example, one isoform may be most abundant in healthy tissue, while another becomes dominant in diseased tissue. Such switching may alter protein domains, coding potential, signal peptides, cellular localization, or regulatory regions. Isoform switching can therefore reveal molecular changes that are not apparent from total gene expression measurements.
  • Several computational tools are available for differential transcript usage analysis. DRIMSeq uses a Dirichlet-multinomial statistical framework to model changes in transcript proportions within genes. DEXSeq was originally developed for differential exon usage and can identify changes in exon-level expression patterns that may indicate alternative splicing. satuRn provides statistical methods for testing differential transcript usage while accounting for transcript-level expression. IsoformSwitchAnalyzeR supports transcript-switch identification and functional interpretation, including predicted changes in coding sequences, protein domains, signal peptides, and NMD sensitivity. SUPPA2 can analyze alternative splicing events using transcript expression estimates, while rMATS focuses on differential alternative splicing events using RNA-seq junction and exon information. The appropriate tool depends on the research question, sequencing design, transcript annotation, and quantification method.
  • Statistical analysis is essential because transcript usage estimates are affected by sequencing depth, gene expression, transcript length, and biological variability. Biological replicates are needed to estimate variation between samples and distinguish consistent transcript-usage changes from random fluctuations. Multiple-testing correction is also important because thousands of genes and transcript isoforms may be examined simultaneously. The Benjamini–Hochberg procedure is commonly used to control the false discovery rate (FDR). Researchers should interpret adjusted p-values together with the magnitude of transcript-usage changes and the biological relevance of the affected isoforms.
  • Differential transcript usage analysis can reveal changes in RNA processing that occur independently of total gene expression. For example, a gene may show no significant differential expression at the gene level but may display a substantial change in the relative abundance of two transcript isoforms. Conversely, a gene may have increased total expression without a meaningful change in transcript usage. Combining differential gene expression, differential transcript expression, and differential transcript usage provides a more complete understanding of transcriptional regulation.
  • Long-read sequencing technologies, including Oxford Nanopore and PacBio sequencing, provide additional opportunities for differential transcript usage analysis. Long reads can span multiple exons and splice junctions within individual RNA molecules, making it easier to distinguish complete transcript isoforms. PacBio Iso-Seq and Oxford Nanopore cDNA or direct RNA sequencing can help identify transcript structures that are difficult to reconstruct from short reads. Tools such as FLAIR, TALON, IsoQuant, and StringTie2 support long-read transcript identification and quantification. Combining short-read and long-read sequencing can improve transcript annotation and the reliability of isoform-level comparisons.
  • Functional interpretation is an important component of differential transcript usage analysis. Researchers may investigate whether transcript switches alter protein domains, coding sequences, signal peptides, binding regions, or untranslated regulatory elements. Resources such as Ensembl, RefSeq, UniProt, InterPro, Gene Ontology (GO), KEGG, and Reactome can support functional annotation. Protein-domain analysis can identify whether alternative transcripts are predicted to produce proteins with different structural or functional characteristics. Integrating transcriptomics with proteomics and ribosome profiling can provide additional evidence about whether transcript-usage changes affect protein production.
  • Differential transcript usage has important applications in disease research. Abnormal transcript-usage patterns have been associated with cancer, neurological disorders, inherited diseases, immune dysfunction, and developmental abnormalities. In cancer, transcript switching may influence cell proliferation, apoptosis, metabolism, and tumor progression. In inherited diseases, changes in transcript processing may produce dysfunctional proteins or transcripts that are degraded through NMD. Differential transcript usage can therefore help identify disease-associated molecular mechanisms, candidate biomarkers, and potential therapeutic targets.
  • In animal genomics and breeding research, differential transcript usage can help explain molecular differences among breeds, tissues, developmental stages, and production environments. Researchers can investigate transcript-usage changes in genes associated with growth, muscle development, milk production, reproductive performance, feed efficiency, immune function, and disease resistance. For example, alternative transcript usage in muscle-related genes may contribute to differences in protein structure and muscle development, while transcript switches in immune-related genes may influence responses to infection. Such findings can help identify candidate regulatory mechanisms underlying economically important traits. However, transcript-usage differences should be validated before being used to support genetic improvement decisions.
  • Several challenges must be considered when interpreting differential transcript usage results. Similar transcript sequences can make accurate quantification difficult, particularly with short-read sequencing. Incomplete transcript annotations may cause unrecognized isoforms to be incorrectly assigned or quantified. Lowly expressed transcripts may have insufficient read coverage, while differences in cell-type composition can create apparent transcript-usage changes between samples. RNA degradation, library preparation, sequencing depth, batch effects, and incorrect statistical assumptions can also influence the results. Appropriate experimental design, quality control, biological replication, and independent validation are therefore essential.
  • Experimental validation can be performed using reverse transcription PCR (RT-PCR), quantitative PCR (qPCR), and targeted sequencing. Primers designed across isoform-specific exon junctions can distinguish transcript variants and confirm changes in their relative abundance. Sanger sequencing can verify the expected exon combinations, while long-read sequencing can provide evidence of complete transcript structures. Northern blotting and proteomics may provide complementary information about transcript size and corresponding protein products. These approaches help determine whether computationally identified transcript-usage changes represent genuine biological events.
  • Overall, differential transcript usage is an important bioinformatics approach for understanding how individual transcript isoforms contribute to gene expression under different biological conditions. RNA-seq, transcript quantification, statistical modeling, alternative splicing analysis, and functional annotation enable researchers to identify changes in transcript composition that may not be detected through gene-level expression analysis. Combining short-read and long-read sequencing with experimental validation improves the identification and interpretation of transcript-usage changes. Differential transcript usage is therefore valuable in transcriptomics, functional genomics, disease research, and animal genomics, particularly for understanding how alternative RNA processing contributes to biological diversity and complex traits.
Author:

Leave a Reply

Your email address will not be published. Required fields are marked *